SCHEMBL6410561

SCHEMBL6410561

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(OC)cc1)C2=O)c1ccccc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
SIGMAR1 Q99720 4/20 0.40
DRD2 P14416 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
CCR5 P51681 1/20 0.39
MMP1 P03956 3/20 0.39
MMP13 P45452 3/20 0.39
MMP9 P14780 2/20 0.39
ADAM17 P78536 2/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.38
ALOX15 P16050 1/20 0.38
USP2 O75604 1/20 0.38
CYP2D6 P10635 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRL1 P41146 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6410554 0.99 SIGMAR1 (0.42) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
SCHEMBL6411851 0.93 MEN1 (0.42) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
Hydrochloric Acid SCHEMBL6411844 0.93 MEN1 (0.42) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
SCHEMBL6411281 0.93 DRD2 (0.42) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
SCHEMBL6408451 0.92 CCR5 (0.42) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
SCHEMBL6410581 0.92 HDAC11 (0.37) ALDH1A1DRD2MMP1MMP13MMP9
Hydrochloric Acid SCHEMBL6408449 0.91 CCR5 (0.41) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
Hydrochloric Acid SCHEMBL6410577 0.91 HDAC11 (0.36) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
Hydrochloric Acid SCHEMBL6408874 0.91 SIGMAR1 (0.41) ALDH1A1SIGMAR1DRD2HTR2AHTR2C
Hydrochloric Acid SCHEMBL6410252 0.91 SIGMAR1 (0.41) ALDH1A1SIGMAR1DRD2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 ALDH1A1 869/4885SIGMAR1 277/4885DRD2 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.